ArticleBiosensors2022

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma.

Pablo J Dopico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.